Nu Skin Enterprises, Inc. (NUS) Announces $0.36 Quarterly Dividend
Nu Skin Enterprises, Inc. (NYSE:NUS) announced a quarterly dividend on Thursday, November 2nd, Wall Street Journal reports. Investors of record on Friday, November 17th will be paid a dividend of 0.36 per share on Wednesday, December 6th. This represents a $1.44 annualized dividend and a dividend yield of 2.26%. The ex-dividend date of this dividend is Thursday, November 16th.
Nu Skin Enterprises has raised its dividend payment by an average of 5.8% per year over the last three years and has increased its dividend every year for the last 16 years. Nu Skin Enterprises has a dividend payout ratio of 44.4% meaning its dividend is sufficiently covered by earnings. Analysts expect Nu Skin Enterprises to earn $3.42 per share next year, which means the company should continue to be able to cover its $1.44 annual dividend with an expected future payout ratio of 42.1%.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.76. The business had revenue of $563.70 million during the quarter, compared to analyst estimates of $562.70 million. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. The company’s revenue was down 6.7% on a year-over-year basis. During the same quarter last year, the business posted $0.98 EPS.
A number of equities analysts have weighed in on NUS shares. Zacks Investment Research upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating in a research note on Wednesday, July 5th. Bank of America Corporation lifted their price objective on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a research note on Monday, July 10th. BidaskClub lowered Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Stifel Nicolaus set a $50.00 price objective on Nu Skin Enterprises and gave the company a “sell” rating in a research note on Thursday, August 3rd. Finally, TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a research note on Wednesday, August 2nd. Three research analysts have rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the stock. Nu Skin Enterprises currently has a consensus rating of “Hold” and an average target price of $62.00.
In other news, Director Daniel W. Campbell sold 4,607 shares of the firm’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $62.48, for a total transaction of $287,845.36. Following the sale, the director now directly owns 63,753 shares in the company, valued at approximately $3,983,287.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Ryan S. Napierski sold 6,933 shares of the firm’s stock in a transaction dated Tuesday, October 10th. The shares were sold at an average price of $64.00, for a total value of $443,712.00. The disclosure for this sale can be found here. Insiders have sold a total of 19,040 shares of company stock worth $1,188,157 over the last 90 days. Insiders own 5.20% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.